1.
Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency,
Clinical and Pathologic Characteristics,
and Diagnosis at Imaging Examinations,
Jin Hee Kim et al.,
adiology: Volume 257: Number 1—October 2010,
RSNA,
2010.
2.
Pietryga JA,
Morgan DE.
Imaging preoperatively for pancreatic adenocarcinoma.
J Gastrointest Oncol 2015;6(4):343-357.
doi: 10.3978/j.issn.2078-6891.2015.024
3.
Isoattenuating Pancreatic Adenocarcinoma at Multi–Detector Row CT: Secondary Signs,
Rupert W.
Prokesch et al,
Radiology 2002; 224:764–768
4.
Pancreatic adenocarcinoma staging in the era of Preoperative Chemotherapy and Radiation therapy,
Zins et al,
Radiology: Volum.e 287: Number 2—May 2018.
5.
Pancreatic Malignancy: Value of Arterial,
Pancreatic,
and Hepatic Phase Imaging with Multi–Detector Row CT,
Joel G.
Fletcher et al,
Radiology 2003; 229:81–90.
6.
Pancreatic Neoplasms: MR Imaging and Pathologic Correlation,
Patricia,
J.
Mergo et al,
RadloGraphics 1997; 17:281-301.
7.
Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria,
Seung Baek Hong et al,
Radiology 2018.
8.
Small (<20 mm) Pancreatic Adenocarcinomas: Analysis of Enhancement Patterns and Secondary Signs with Multiphasic Multidetector CT,
Soon Ho Yoon et al,
Radiology: Volume 259: Number 2—May 2011.
9. Agostini S.
Radioanatomie du pancréas.
EMC (Elsevier Masson SAS,
Paris),
Radiologie et imagerie médicale - abdominale - digestive,
33-650-A-10,
2010.